Trial · NCT03409107
Results by group96
Each measurement the trial posted, group by group, in the words and numbers it posted.
61 to 80 of 96
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days | Placebo | Week 8, n=50, 39 | 0.1 | Standard Deviation 18.46 | Percentage of hours |
| Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days | Daprodustat | Week 8, n=50, 39 | -1.8 | Standard Deviation 11.88 | Percentage of hours |
| Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days | Placebo | Week 12, n=46, 31 | 1.4 | Standard Deviation 14.07 | Percentage of hours |
| Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days | Daprodustat | Week 12, n=46, 31 | 2.4 | Standard Deviation 16.83 | Percentage of hours |
| Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days | Placebo | Week 28, n=28, 25 | 0.3 | Standard Deviation 19.90 | Percentage of hours |
| Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days | Daprodustat | Week 28, n=28, 25 | 1.0 | Standard Deviation 14.24 | Percentage of hours |
| Change From Baseline in WPAI: Percent Impairment at Work | Placebo | Week 8, n=45, 32 | -5.1 | Standard Deviation 18.42 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Impairment at Work | Daprodustat | Week 8, n=45, 32 | -11.3 | Standard Deviation 24.06 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Impairment at Work | Placebo | Week 12, n=41, 26 | -4.6 | Standard Deviation 18.99 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Impairment at Work | Daprodustat | Week 12, n=41, 26 | -8.8 | Standard Deviation 23.38 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Impairment at Work | Placebo | Week 28, n=24, 20 | -9.6 | Standard Deviation 25.62 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Impairment at Work | Daprodustat | Week 28, n=24, 20 | -9.0 | Standard Deviation 22.92 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Overall Work Impairment | Placebo | Week 8, n=45, 32 | -4.3 | Standard Deviation 24.04 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Overall Work Impairment | Daprodustat | Week 8, n=45, 32 | -12.0 | Standard Deviation 25.90 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Overall Work Impairment | Placebo | Week 12, n=41, 26 | 0.5 | Standard Deviation 25.81 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Overall Work Impairment | Daprodustat | Week 12, n=41, 26 | -3.2 | Standard Deviation 33.35 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Overall Work Impairment | Placebo | Week 28, n=24, 20 | -9.3 | Standard Deviation 37.45 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Overall Work Impairment | Daprodustat | Week 28, n=24, 20 | -8.4 | Standard Deviation 19.12 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Regular Daily Activity Impairment | Placebo | Week 8, n=243, 248 | -4.6 | Standard Deviation 23.67 | Percentage of impairment |
| Change From Baseline in WPAI: Percent Regular Daily Activity Impairment | Daprodustat | Week 8, n=243, 248 | -7.7 | Standard Deviation 24.53 | Percentage of impairment |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03409107/results?page=4